Infections associated with use of the LifeSite Hemodialysis Access System.
We observed infection rates associated with the LifeSite Hemodialysis Access System, a novel dialysis device consisting of 2 subcutaneously implanted valves accessed by repeated use of fibrous tissue tracts, of 4.8 total infections and 8.1 first episodes per 1000 patient-days. These rates are higher than those observed elsewhere, which may be related to use of the device in a population of chronically ill patients, to the learning curve associated with use of the device, or to inherent qualities of the device.
Ross
John J
JJ
Division of Infectious Disease, St. Elizabeth's Medical Center, Boston, MA, 02135, USA. jrossmd@cchcs.org
Narayan
Geetha
G
Bergeron
Ellen K
EK
Worthington
Michael G
MG
Strom
James A
JA
D002408:Catheters, Indwelling / Q000382:microbiology; D003141:Communicable Diseases / Q000209:etiology* / Q000401:mortality; D006801:Humans; D016459:Prosthesis-Related Infections / Q000209:etiology* / Q000401:mortality; D006435:Renal Dialysis / Q000009:adverse effects* / Q000295:instrumentation / Q000379:methods